Skip to main content

Advertisement

SpringerLink
Log in

Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer

  • Review – Cancer Research
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Most of the nanomedicines for treatment of multidrug-resistant cancer do not reach Phase III trials and many are terminated or withdrawn or are in an indeterminate state since long without any study results being presented. Extensive perusal of nanomedicine development research revealed that one of the critical aspects influencing clinical outcomes and which requires diligent scrutiny is selection process of nanodelivery system.

Methods

Research papers and articles published on development of nanodelivery systems for treatment of multidrug-resistant cancer were analyzed. Observations and conclusions noted by these researchers which might shed some light on poor clinical performance of nanocarriers were collated and summarized under observation section. Further research articles were studied to find possible solutions which may be applied to these particular problems for resolving them. The inferences of these findings were composed in Result section.

Result

Plausible solutions for the observed obstacles were noted as examples of novel formulations that can yield the following: better in vivo imaging, precise targeting and dosing of a specific site and specific cell type in a particular cancer, modulation of tumor surroundings, intonation of systemic effects and high reproducibility.

Conclusion

The angle of approach to the development of best nanosystem for a specific type of tumor needs to be spun around. Some of these changes can be brought about by individual scientists, some need to be established by collated efforts of scientists globally and some await advent of better technologies. Regardless of the stratagem, it can be said decisively that the schematics of development phase need rethinking.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alakhova DY, Kabanov AV (2014) Pluronics and MDR reversal: an update. Mol Pharm 11:2566–2578

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Alakhova DY, Rapoport NY, Batrakova EV, Timoshin AA, Li S, Nicholls D, Alakhov VY, Kabanov AV (2010) Differential metabolic responses to Pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers. J Control Release 142:89–100

    Article  CAS  PubMed  Google Scholar 

  • Anreddy N, Patel A, Sodani K, Kathawala RJ, Chen EP, Wurpel JND, Chen Z (2014) PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR. Acta Pharm Sin B 4:202–207

    Article  PubMed  PubMed Central  Google Scholar 

  • Arts JHE, Hadi M, Irfan MA, Keene AM, Kreiling R, Lyon D et al (2015) A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). Regul Toxicol Pharmacol 71:S1–S27

    Article  CAS  PubMed  Google Scholar 

  • Attia AB, Yang C, Tan JP, Gao S, Williams DF, Hedrick JL, Yang YY (2013) The effect of kinetic stability on biodistribution and anti-tumor efficacy of drug-loaded biodegradable polymeric micelles. Biomaterials 34:3132–3140

    Article  PubMed  CAS  Google Scholar 

  • Bai F, Wang C, Lu Q, Zhao M, Ban FQ, Yu DH, Guan YY, Luan X, Liu YR, Chen HZ, Fang C (2013) Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer. Biomaterials 34:6163–6174

    Article  CAS  PubMed  Google Scholar 

  • Bandekar A, Zhu C, Jindal R, Bruchertseifer F, Morgenstern A, Sofou S (2014) Anti-prostate-specific membrane antigen liposomes loaded with 225Ac for potential targeted antivascular α-particle therapy of cancer. J Nucl Med 55:107–114

    Article  CAS  PubMed  Google Scholar 

  • Bao Y, Guo Y, Zhuang X, Li D, Cheng B, Tan S, Zhang Z (2014) D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Mol Pharm 11:3196–3209

    Article  CAS  PubMed  Google Scholar 

  • Batrakova EV, Kabanov AV (2008) Evolution of drug delivery concept from inert nanocarriers to biological response modifiers, Pluronic block copolymers. J Control Release 130:98–106

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Batrakova EV, Li S, Elmquist WF, Miller DW, Alakhov VY, Kabanov AV (2001a) Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion. Br J Cancer 85:1987–1997

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Batrakova EV, Li S, Vinogradov SV, Alakhov VY, Miller DW, Kabanov AV (2001b) Mechanism of pluronic effect on P-glycoprotein efflux system in blood–brain barrier: contributions of energy depletion and membrane fluidization. J Pharm Exp Therap 299:483–493

    CAS  Google Scholar 

  • Britton C, Winter AD, Gillan V, Devaney E (2014) microRNAs of parasitic helminths—identification, characterization and potential as drug targets. Int J Parasitol Drugs Drug Resist 4:85–94

    Article  PubMed  PubMed Central  Google Scholar 

  • Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K (2001) Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 175:191–199

    Article  CAS  PubMed  Google Scholar 

  • Bushman J, Vaughan A, Sheihet L, Zhang Z, Costache M, Kohn J (2013) Functionalized nanospheres for targeted delivery of paclitaxel. J Control Release 171:315

    Article  CAS  PubMed  Google Scholar 

  • Butt AM, Amin MCM, Katas H (2015) Synergistic effect of pH-responsive folate-functionalized poloxamer 407-TPGS-mixed micelles on targeted delivery of anticancer drugs. Int J Nanomed 10:1321–1334

    CAS  Google Scholar 

  • Chen Y, Yin Q, Ji X, Zhang S, Chen H, Zheng Y, Sun Y, Qu H, Wang Z, Li Y, Wang X, Zhang K, Zhang L, Shi J (2012) Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. Biomaterials 33:7126–7137

    Article  CAS  PubMed  Google Scholar 

  • Chen SY, Hu SS, Dong Q, Xing JF, Lu J, Dong YL et al (2013) Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo. Asian Pac J Cancer Prev 14:6135–6140

    Article  PubMed  Google Scholar 

  • Chen S, Cai J, Zhang W, Zheng X, Hu S, Lu J, Xing J, Dong Y (2014) Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells. Int J Oncol 45:448–458

    CAS  PubMed  Google Scholar 

  • Chen J, Liu Q, Xiao J, Du J (2015a) EpCAM-antibody-labeled noncytotoxic polymer vesicles for cancer stem cells-targeted delivery of anticancer drug and siRNA. Biomacromolecules 16:1695–1705

    Article  CAS  PubMed  Google Scholar 

  • Chen Y, Zhang W, Huang Y, Gao F, Sha X, Fang X (2015b) Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor. Int J Pharm 488:44–58

    Article  CAS  PubMed  Google Scholar 

  • Cheng J, Gu YJ, Cheng SH, Wong WT (2013) Surface functionalized gold nanoparticles for drug delivery. J Biomed Nanotechnol 9:1362–1369

    Article  CAS  PubMed  Google Scholar 

  • Coley HM, Labeed FH, Thomas H, Hughes MP (2007) Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivity. Biochimica et Biophysica Acta (BBA) Gen Subj 1770:601–608

    Article  CAS  Google Scholar 

  • Daniela C, Bella C, Burtona C, Harguindeyb S, Reshkinc SJ, Raucha C (2013) The role of proton dynamics in the development and maintenance of multidrug resistance in cancer. Biochimica et Biophysica Acta (BBA) Mol Basis Dis 1832:606–617

    Article  CAS  Google Scholar 

  • Davoudi Z, Akbarzadeh A, Rahmatiyamchi M, Sadeghi Z, Dariushnejad H, Zarghami N (2014) Molecular target therapy of AKT and NF-kB signaling pathways and multidrug resistance by specific cell penetrating inhibitor peptides in HL-60 cells. Asian Pac J Cancer Prev 15:4353–4358

    Article  PubMed  Google Scholar 

  • de Verdière AC, Dubernet C, Nemati F, Poupon MF, Puisieux F, Couvreur P (1994) Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells. Cancer Chemother Pharmacol 33:504–508

    Article  Google Scholar 

  • Deng Y, Zhang H (2013) The synergistic effect and mechanism of doxorubicin-ZnO nanocomplexes as a multimodal agent integrating diverse anticancer therapeutics. Int J Nanomed 8:1835–1841

    Google Scholar 

  • Ding Z, Xu F, Li G, Tang J, Tang Z, Jiang P, Wu H (2014) Knockdown of Akt2 expression by ShRNA inhibits proliferation, enhances apoptosis, and increases chemosensitivity to paclitaxel in human colorectal cancer cells. Cell Biochem Biophys 71:383–388

    Article  CAS  Google Scholar 

  • Docter D, Strieth S, Westmeier D, Hayden O, Gao M, Knauer SK, Stauber RH (2015) No king without a crown—impact of the nanomaterial-protein corona on nanobiomedicine. Nanomedicine 10:503–519

    Article  CAS  PubMed  Google Scholar 

  • Donaldson K, Poland CA (2013) Nanotoxicity: challenging the myth of nano-specific toxicity Curr. Opin Biotechnol 24:724–734

    Article  CAS  Google Scholar 

  • Duan X, Xiao J, Yin Q, Zhang Z, Yu H, Mao S, Li Y (2013) Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano 7:5858–5869

    Article  CAS  PubMed  Google Scholar 

  • Duffin R, Tran L, Brown D, Stone V, Donaldson K (2007) Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 19:849–856

    Article  CAS  PubMed  Google Scholar 

  • Ekdawi SN, Stewart JM, Dunne M, Stapleton S, Mitsakakis N, Dou YN, Jaffray DA, Allen C (2015) Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model. J Control Release 207:101–111

    Article  CAS  PubMed  Google Scholar 

  • Elumalai R, Patil S, Maliyakkal N, Rangarajan A, Kondaiah P, Raichur AM (2015) Protamine-carboxymethyl cellulose magnetic nanocapsules for enhanced delivery of anticancer drugs against drug resistant cancers. Nanomedicine 11:969–981

    CAS  PubMed  Google Scholar 

  • Esmatabadi MJD, Farhangi B, Safari Z, Kazerooni H, Shirzad H, Zolghadr F, Sadeghizadeh M (2015) Dendrosomal curcumin inhibits metastatic potential of human SW480 colon cancer cells through Down-regulation of Claudin1, Zeb1 and Hef1-1 gene expression. Asian Pac J Cancer Prev 16:2473–2481

    Article  Google Scholar 

  • Farhangi B, Alizadeh AM, Khodayari H, Khodayari S, Dehghan MJ, Khori V, Heidarzadeh A, Khaniki M, Sadeghiezadeh M, Najafi F (2015) Protective effects of dendrosomal curcumin on an animal metastatic breast tumor. Eur J Pharmacol 758:188–196

    Article  CAS  PubMed  Google Scholar 

  • Gagné D, French RL, Narayanan C, Simonović M, Agarwal PK, Doucet N (2015) Perturbation of the conformational dynamics of an active-site loop alters enzyme activity. Structure 23:2256–2266

    Article  PubMed  CAS  Google Scholar 

  • Gallus J, Juvale K, Wiese M (2014) Characterization of 3-methoxy flavones for their interaction with ABCG2 as suggested by ATPase activity. Biochim Biophys Acta 1838:2929–2938

    Article  CAS  PubMed  Google Scholar 

  • Ganguly A, Banerjee K, Chakraborty P, Chatterjee M, Mondal NB, Choudhuri SK et al (2011) Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative. Biomed Pharmacother 65:387–394

    Article  CAS  PubMed  Google Scholar 

  • Gao Y, Chen Y, Ji X, He X, Yin Q, Zhang Z, Shi J, Li Y (2011) Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. ACS Nano 5:9788–9798

    Article  CAS  PubMed  Google Scholar 

  • Guan YY, Luan X, Xu JR, Liu YR, Lu Q, Wang C, Liu HJ, Gao YG, Chen HZ, Fang C (2014) Selective eradication of tumor vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis. Biomaterials 35:3060–3070

    Article  CAS  PubMed  Google Scholar 

  • Guo Y, Chu M, Tan S, Zhao S, Liu H, Otieno BO, Yang X, Xu C, Zhang Z (2014) Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Mol Pharm 11:59–70

    Article  CAS  PubMed  Google Scholar 

  • Hall AP (2006) Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy. Toxicol Pathol 34:763–775

    Article  CAS  PubMed  Google Scholar 

  • Han M, Diao YY, Jiang HL, Ying XY, Chen DW, Liang WQ, Gao JQ (2011) Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle. Int J Pharm 420:404–411

    Article  CAS  PubMed  Google Scholar 

  • Henry-Toulmé N, Grouselle M, Ramaseilles C (1995) Multidrug resistance bypass in cells exposed to doxorubicin-loaded nanospheres. Absence of endocytosis. Biochem Pharmacol 50:1135–1139

    Article  PubMed  Google Scholar 

  • Hinton C, Antony H, Hashimi SM, Munn A, Wei MQ (2013) Significance of prion and prion-like proteins in cancer development, progression and multi-drug resistance. Curr Cancer Drug Targets 13:895–904

    Article  CAS  PubMed  Google Scholar 

  • Hong W, Chen D, Zhang X, Zeng J, Hu H, Zhao X, Qiao M (2013) Reversing multidrug resistance by intracellular delivery of Pluronic® P85 unimers. Biomaterials 34:9602–9614

    Article  CAS  PubMed  Google Scholar 

  • Hossain DM, Panda AK, Chakrabarty S, Bhattacharjee P, Kajal K, Mohanty S, Sarkar I, Sarkar DK, Kar SK, Sa G (2015) MEK inhibition prevents tumor-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumor milieu. Immunology 144:561–573

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hu YP, Henry-Toulmé N, Robert J (1995) Failure of liposomal encapsulation of doxorubicin to circumvent multidrug resistance in an in vitro model of rat glioblastoma cells. Eur J Cancer 31:389–394

    Article  Google Scholar 

  • Hu Y, Cheng X, Li S, Zhou Y, Wang J, Cheng T, Yang M, Xiong D (2013) Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins. Cancer Chemother Pharmacol 72:789–798

    Article  CAS  PubMed  Google Scholar 

  • Hu X, Jiang D, Li F, Wu Z, Huang Y, Song S, Wang Z (2014) Ergosterol reverses multidrug resistance in SGC7901/Adr cells. Pharmazie 69:396–400

    CAS  PubMed  Google Scholar 

  • Huang IP, Sun SP, Cheng SH, Lee CH, Wu CY, Yang CS, Lo LW, Lai YK (2011) Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance. Mol Cancer Ther 10:761–769

    Article  CAS  PubMed  Google Scholar 

  • Hung TH, Chen CM, Tseng CP, Shen CJ, Wang HL, Choo KB, Chong KY (2014) FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancercells. Int J Biochem Cell Biol 53C:55–65

    Article  CAS  Google Scholar 

  • Jaiswal R, Grau GER, Bebawy M (2014) Cellular communication via microparticles: role in transfer of multidrug resistance in cancer. Future Oncol 10:655–669

    Article  CAS  PubMed  Google Scholar 

  • Januchowski R, Zawierucha P, Ruciński M, Andrzejewska M, Wojtowicz K, Nowicki M, Zabel M (2014) Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line. Biomed Pharmacother 68:447–453

    Article  CAS  PubMed  Google Scholar 

  • Jhaveri MA, Torchilin VP (2014) Multifunctional polymeric micelles for delivery of drugs and siRNA. Front Pharmacol 5:77

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Jia M, Hu J, Li W, Su P, Zhang H, Zhang X, Zhou G (2014) Trps1 is associated with the multidrug resistance of osteosarcoma by regulating MDR1 gene expression. FEBS Lett 588:801–810

    Article  CAS  PubMed  Google Scholar 

  • Jin X, Mo R, Ding Y, Zheng W, Zhang C (2014) Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance. Mol Pharm 11:145–157

    Article  CAS  PubMed  Google Scholar 

  • Kabanov AV, Batrakova EV, Miller DW (2003) Pluronic block copolymers as modulators of drug efflux transporter activity in the blood–brain barrier. Adv Drug Deliv Rev 55:151–164

    Article  CAS  PubMed  Google Scholar 

  • Ke XY, Lin VWN, Gao SJ, Tong YW, Hedrick JL, Yang YY (2014) Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells. Biomaterials 35:1096–1108

    Article  CAS  PubMed  Google Scholar 

  • Kettler K, Veltman K, van de Meent D, van Wezel A, Hendriks AJ (2014) Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type. Environ Toxicol Chem 33:481–492

    Article  CAS  PubMed  Google Scholar 

  • Kim JA, Salvati A, Åberg C, Dawson KA (2014) Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafety. Nanoscale 23:14180–14184

    Article  CAS  Google Scholar 

  • Kopecka J, Campia I, Olivero P, Pescarmona G, Ghigo D, Bosia A, Riganti C (2011) A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells. J Control Release 149:196–205

    Article  CAS  PubMed  Google Scholar 

  • Krishna R, Mayer LD (1997) Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors. Cancer Res 57:5246–5253

    CAS  PubMed  Google Scholar 

  • Krishnamurthy S, Ng VW, Gao S, Tan MH, Yang YY (2014) Phenformin-loaded polymeric micelles for targeting both cancer cells and cancer stem cells in vitro and in vivo. Biomaterials 35:9177–9186

    Article  CAS  PubMed  Google Scholar 

  • Krishnamurthy S, Ke X, Yang YY (2015) Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells. Nanomedicine 10:143–160

    Article  CAS  PubMed  Google Scholar 

  • Krpetić Z, Anguissola S, Garry D, Kelly PM, Dawson KA (2014) Nanomaterials: impact on cells and cell organelles. Adv Exp Med Biol 811:135–156

    Article  PubMed  CAS  Google Scholar 

  • Lai J, Shah BP, Zhang Y, Yang L, Lee KB (2015) Real-time monitoring of ATP-responsive drug release using mesoporous-silica-coated multicolor upconversion nanoparticles. ACS Nano 9:5234–5245

    Article  CAS  PubMed  Google Scholar 

  • Landsiedel R, Sauer UG, Ma-Hock L, Schnekenburger J, Wiemann M (2014) Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies. Nanomedicine 9:2557–2585

    Article  CAS  PubMed  Google Scholar 

  • Lee Y, Park SY, Mok H, Park TG (2008) Synthesis, characterization, antitumor activity of pluronic mimicking copolymer micelles conjugated with doxorubicin via acid-cleavable linkage. Bioconjug Chem 19:525–531

    Article  CAS  PubMed  Google Scholar 

  • Lesniak A, Fenaroli F, Monopoli MP, Åberg C, Dawson KA, Salvati A (2012) Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6:5845–5857

    Article  CAS  PubMed  Google Scholar 

  • Lespinea A, Méneza C, Bourguinatb C, Prichard RK (2012) P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: prospects for reversing transport-dependent anthelmintic resistance. Int J Parasitol Drugs Drug Resist 2:58–75

    Article  CAS  Google Scholar 

  • Li F, Mahato RI (2014) MicroRNAs and drug resistance in prostate cancers. Mol Pharm 11:2539–2552

    Article  CAS  PubMed  Google Scholar 

  • Li L, Huang X, Liu T, Liu H, Hao N, Chen D, Zhang Y, Li L, Tang F (2012a) Overcoming multidrug resistance with mesoporous silica nanorods as nanocarrier of doxorubicin. J Nanosci Nanotechnol 12:4458–4466

    Article  CAS  PubMed  Google Scholar 

  • Li B, Xu H, Li Z, Yao M, Xie M, Shen H, Shen S, Wang X, Jin Y (2012b) Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies. Int J Nanomed 7:187–197

    CAS  Google Scholar 

  • Li WJ, Zhong SL, Wu YJ, Xu WD, Xu JJ, Tang JH, Zhao JH (2013) Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines. Mol Biol Rep 40:6143–6150

    Article  CAS  PubMed  Google Scholar 

  • Li Y, Tan BB, Zhao Q, Fan LQ, Liu Y, Wang D (2014) Regulatory mechanism of ZNF139 in multi-drug resistance of gastric cancer cells. Mol Biol Rep 41:3603–3610

    Article  CAS  PubMed  Google Scholar 

  • Li K, Su Q, Yuan W, Tian B, Shen B, Li Y, Feng W, Li F (2015) Ratiometric monitoring of intracellular drug release by an upconversion drug delivery nanosystem. ACS Appl Mater Interfaces 7:12278–12286

    Article  CAS  PubMed  Google Scholar 

  • Liang H, Li X, Chen B, Wang B, Zhao Y, Zhuang Y, Shen H, Zhang Z, Dai J (2015) A collagen-binding EGFR single-chain Fv antibody fragment for the targeted cancer therapy. J Control Release 209:101–109

    Article  CAS  PubMed  Google Scholar 

  • Linse S, Cabaleiro-Lago C, Xue WF, Lynch I, Lindman S, Thulin E, Radford SE, Dawson KA (2007) Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci USA 104:8691–8696

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu Y, Wang W, Yang J, Zhou C, Sun J (2013) pH-sensitive polymeric micelles triggered drug release for extracellular and intracellular drug targeting delivery. Asian J Pharm Sci 8:159–167

    Article  Google Scholar 

  • Liu HS, Tan WB, Yang N, Yang YY, Cheng P, Liu LJ, Wang WJ, Zhu CL (2014a) Effects of ribosomal protein l39-L on the drug resistance mechanisms of lung cancer A549 cells. Asian Pac J Cancer Prev 15:3093–3097

    Article  PubMed  Google Scholar 

  • Liu L, Zuo F, Guo JW (2014b) ABCG2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance. Mol Med Rep 9:1299–1304

    CAS  PubMed  Google Scholar 

  • Liu YR, Guan YY, Luan X, Lu Q, Wang C, Liu HJ, Gao YG, Yang SC, Dong X, Chen HZ, Fang C (2015) Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy. Biomaterials 42:161–171

    Article  CAS  PubMed  Google Scholar 

  • Löschmann N, Michaelis M, Rothweiler F, Ghafourian T, Westermann F, Cinatl J Jr (2013) Testing of SNS-032 in a panel of human neuroblastoma cell lines with acquired resistance to a broad range of drugs. Transl Oncol 6:685

    Article  PubMed  PubMed Central  Google Scholar 

  • Lynch I, Dawson KA (2008) Protein-nanoparticle interactions. Nano Today 3:40–47

    Article  CAS  Google Scholar 

  • Ma H, Zhou H, Song X, Shi S, Zhang J, Jia L (2014) Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia. Oncogene 34:726–740

    Article  PubMed  CAS  Google Scholar 

  • Mariam J, Sivakami S, Dongre PM (2015) Albumin corona on nanoparticles—a strategic approach in drug delivery. Drug Deliv 16:1–9

    Article  Google Scholar 

  • Markman JL, Rekechenetskiy A, Holler E, Ljubimova JY (2013) Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv Drug Deliv Rev 65:1866–1879

    Article  CAS  PubMed  Google Scholar 

  • Mattix B, Moore T, Uvarov O, Pollard S, O’Donnell L, Park K, Horne D, Dhulekar J, Reese L, Nguyen D, Kraveka J, Burg K, Alexis F (2013) Effects of polymeric nanoparticle surface properties on interaction with brain tumor environment. Nano Life 3:1343003

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Minkoa T, Rodriguez-Rodriguezb L, Pozharova V (2013) Nanotechnology approaches for personalized treatment of multidrug resistant cancers. Adv Drug Deliv Rev 65:1880–1895

    Article  CAS  Google Scholar 

  • Mirgani MT, Isacchi B, Sadeghizadeh M, Marra F, Bilia AR, Mowla SJ, Najafi F, Babaei E (2014) Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells. Int J Nanomed 9:403–417

    Google Scholar 

  • Misra R, Sahoo SK (2011) Coformulation of doxorubicin and curcumin in poly(D, L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Mol Pharm 8:852–866

    Article  CAS  PubMed  Google Scholar 

  • Mo R, Jin X, Li N, Ju C, Sun M, Zhang C, Ping Q (2011) The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. Biomaterials 32:4609–4620

    Article  CAS  PubMed  Google Scholar 

  • Moghadam BY, Hou WC, Corredor C, Westerhoff P, Posner JD (2012) The role of nanoparticle surface functionality in the disruption of model cell membranes. Langmuir 28:16318–16326

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • National Cancer Institute (2010) Focusing on older cancer patients: a clinical need and a research necessity. National Cancer Institute, Rockville

    Google Scholar 

  • National Cancer Institute (2012) Targeted nanoparticle tested in patients with cancer. National Cancer Institute, Rockville

    Google Scholar 

  • Niravkumar R, Patel Bhushan S, Pattni Abraham HA, Torchilin PV (2013) Nanopreparations to overcome multidrug resistance in cancer. Adv Drug Deliv Rev 65:1748–1762

    Article  CAS  Google Scholar 

  • Nishida Y, Mizutani N, Inoue M, Ohnishi K, Naoe T, Murate T (2014) Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines. Biochim Biophys Acta 1839:265–274

    Article  CAS  PubMed  Google Scholar 

  • Oberdörster G (2009) Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Int Med 267:89–105

    Article  CAS  Google Scholar 

  • Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H (2005) ILSI Research Foundation Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Pan L, Liu J, He Q, Wang L, Shi J (2013) Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles. Biomaterials 34:2719–2730

    Article  CAS  PubMed  Google Scholar 

  • Patil S, Sandberg A, Heckert E, Self W, Seal S (2007) Protein absorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials 28:4600–4607

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pedrini I, Gazzano E, Chegaev K, Rolando B, Marengo A, Kopecka J, Fruttero R, Ghigo D, Arpicco S, Riganti C (2014) Liposomal nitrooxy-doxorubicin: one step over caelyx in drug-resistant human cancer cells. Mol Pharm 11:3068–3079

    Article  CAS  PubMed  Google Scholar 

  • Peetla C, Vijayaraghavalu S, Labhasetwar V (2013) Biophysics of cell membrane lipids in cancer drug resistance: implications for drug transport and drug delivery with nanoparticles. Adv Drug Deliv Rev 65:1686–1698

    Article  CAS  PubMed  Google Scholar 

  • Peng F, Su Y, Ji X, Zhong Y, Wei X, He Y (2014) Doxorubicin-loaded silicon nanowires for the treatment of drug-resistant cancer cells. Biomaterials 35:5188–5195

    Article  CAS  PubMed  Google Scholar 

  • Pilapong C, Keereeta Y, Munkhetkorn S, Thongtem S, Thongtem T (2014) Enhanced doxorubicin delivery and cytotoxicity in multidrug resistant cancer cells using multifunctional magnetic nanoparticles. Colloids Surf B Biointerfaces 113:249–253

    Article  CAS  PubMed  Google Scholar 

  • Ping M, Russell J (2013) Anthracycline nano-delivery systems to overcome multiple drug resistance: a comprehensive review. Nano Today 8:313–331

    Article  CAS  Google Scholar 

  • Qin Y, Bao H, Pan Y, Yin M, Liu Y, Wu S, Li H (2014) SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma. Mol Med Rep 9:877–881

    CAS  PubMed  Google Scholar 

  • Rao W, Wang H, Han J, Zhao S, Dumbleton J, Agarwal P, Zhang W, Zhao G, Yu J, Zynger DL, Lu X, He X (2015) Chitosan-decorated doxorubicin-encapsulated nanoparticle targets and eliminates tumor reinitiating cancer stem-like cells. ACS Nano 9:5725–5740

    Article  CAS  PubMed  Google Scholar 

  • Reidy B, Haase A, Luch A, Dawson KA, Lynch I (2013) Mechanisms of silver nanoparticle release, transformation and toxicity: a critical review of current knowledge and recommendations for future studies and applications. Materials 6:2295–2350

    Article  CAS  Google Scholar 

  • Ren T, Wu W, Jia M, Dong H, Li Y, Ou Z (2013) Reduction-cleavable polymeric vesicles with efficient glutathione-mediated drug release behavior for reversing drug resistance. ACS Appl Mater Interfaces 5:10721–10730

    Article  CAS  PubMed  Google Scholar 

  • Riganti C, Voena C, Kopecka J (2011) Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells. Mol Pharm 8:683–700

    Article  CAS  PubMed  Google Scholar 

  • Riganti C, Rolando B, Kopecka J, Campia I, Chegaev K, Lazzarato L, Federico A, Fruttero R, Ghigo D (2013) Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance. Mol Pharm 10:161–174

    Article  CAS  PubMed  Google Scholar 

  • Roncuzzi L, Pancotti F, Baldini N (2014) Involvement of HIF-1α activation in the doxorubicin resistance of human osteosarcoma cells. Oncol Rep 32:389–394

    CAS  PubMed  Google Scholar 

  • Rushton EK, Jiang J, Leonard SS, Eberly S, Castranova V, Biswas P, Elder A, Han X, Gelein R, Finkelstein J, Oberdörster G (2010) Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J Toxicol Environ Health A 73:445–461

    Article  CAS  PubMed  Google Scholar 

  • Saeed M, Khalid H, Sugimoto Y, Efferth T (2014) The lignan, (−)-sesamin reveals cytotoxicity toward cancer cells: pharmacogenomic determination of genes associated with sensitivity or resistance. Phytomedicine 21:689–696

    Article  CAS  PubMed  Google Scholar 

  • Satpati D, Korde A, Sarma HD, Banerjee S (2014) Radiosynthesis and biological evaluation of 68 Ga-labeled colchicine conjugates. Cancer Biother Radiopharm 29:251–256

    Article  CAS  PubMed  Google Scholar 

  • Saxena V, Hussain MD (2012) Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer. Int J Nanomed 7:713–721

    CAS  Google Scholar 

  • Schumacher U, Nehmann N, Adam E, Mukthar D, Schlegelberger B, Steinemann D et al (2012) MDR-1-overexpression in HT 29 colon cancer cells grown in SCID mice. Acta Histochem 114:594–602

    Article  CAS  PubMed  Google Scholar 

  • Senkiv Y, Riabtseva A, Heffeter P, Boiko N, Kowol CR, Jungwith U, Shlyakhtina Y, Garasevych SG, Mitina N, Berger W, Zaichenko A, Stoika R (2014) Enhanced anticancer activity and circumvention of resistance mechanisms by novel polymeric/phospholipidic nanocarriers of doxorubicin. J Biomed Nanotechnol 10:1369–1381

    Article  CAS  PubMed  Google Scholar 

  • Shalviri A, Raval G, Prasad P, Chan C, Liu Q, Heerklotz H, Rauth AM, Wu XY (2012) pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells. Eur J Pharm Biopharm 82:587–597

    Article  CAS  PubMed  Google Scholar 

  • Shemetov AA, Nabiev I, Sukhanova A (2012) Molecular interaction of proteins and peptides with nanoparticles. ACS Nano 6:4585–4602

    Article  CAS  PubMed  Google Scholar 

  • Shen J, He Q, Gao Y, Shi J, Li Y (2011) Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism. Nanoscale 3:4314–4322

    Article  CAS  PubMed  Google Scholar 

  • Shiri S, Alizadeh AM, Baradaran B, Farhanghi B, Shanehbandi D, Khodayari S, Khodayari H, Tavassoli A (2015) Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing m1/m2 macrophage balance in the tumor microenvironment. Asian Pac J Cancer Prev 16:3917–3922

    Article  PubMed  Google Scholar 

  • Shrivastavaa S, Singha SK, Mukhopadhyaya A, Sinhab ASK, Mandalc RK, Dasha D (2011) Negative regulation of fibrin polymerization and clot formation by nanoparticles of silver. Colloid Surf B 82:241–246

    Article  CAS  Google Scholar 

  • Sun YF, Wink M (2014) Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells. Phytomedicine 21:1110–1119

    Article  CAS  PubMed  Google Scholar 

  • Takwi AA, Wang YM, Wu J, Michaelis M, Cinatl J, Chen T (2014) miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells. Oncogene 33:3717–3729

    Article  CAS  PubMed  Google Scholar 

  • Tang L, Tong R, Coyle VJ, Yin Q, Pondenis H, Borst LB, Cheng J, Fan TM (2015) Targeting tumor vasculature with aptamer-functionalized Doxorubicin-polylactide nanoconjugates for enhanced cancer therapy. ACS Nano 9:5072–5081

    Article  CAS  PubMed  Google Scholar 

  • Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG (2007) Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol Sci 95:212–300 (Erratum in: Toxicol Sci 97:614)

    Google Scholar 

  • Tezcan O, Gündüz U (2014) Vimentin silencing effect on invasive and migration characteristics of doxorubicin resistant MCF-7 cells. Biomed Pharmacother 68:357–364

    Article  CAS  PubMed  Google Scholar 

  • UCD Dublin Research News Archive (2011) New insights into nanoparticles and dividing cells

  • Wang J, Fan Y (2014) Lung injury induced by TiO2 nanoparticles depends on their structural features: size, shape, crystal phases, and surface coating. Int J Mol Sci 15:22258–22278

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang J, Qu H, Jin L, Zeng W, Qin L, Zhang F, Wei X, Lu W, Zhang C, Liang W (2011a) PEGylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells. J Pharm Sci 100:2267–2277

    Article  CAS  PubMed  Google Scholar 

  • Wang F, Wang YC, Dou S, Xiong MH, Sun TM, Wang J (2011b) Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano 24:3679–3692

    Article  CAS  Google Scholar 

  • Wang YC, Wang F, Sun TM, Wang J (2011c) Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells. Bioconjug Chem 22:1939–1945

    Article  CAS  PubMed  Google Scholar 

  • Wang F, Zhang D, Zhang Q, Chen Y, Zheng D, Hao L, Duan C, Jia L, Liu G, Liu Y (2011d) Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance. Biomaterials 32:9444–9456

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Guo M, Lu Y, Ding LY, Ron WT, Liu YQ, Song FF, Yu SQ (2012a) Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Nanotechnology 23:495–503

    Google Scholar 

  • Wang J, Sun J, Chen Q, Gao Y, Li L, Li H, Leng D, Wang Y, Sun Y, Jing Y, Wang S, He Z (2012b) Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol. Biomaterials 33:6877–6888

    Article  CAS  PubMed  Google Scholar 

  • Wang YJ, Kathawala RJ, Zhang YK, Patel A, Kumar P, Shukla S, Fung KL, Ambudkar SV, Talele TT, Chen ZS (2014a) Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1. Biochem Pharmacol 90:367–378

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang DS, Patel A, Sim HM, Zhang YK, Wang YJ, Kathawala RJ, Chen ZS (2014b) ARRY-334543 Reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2. J Cell Biochem 115:1381–1391

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang H, Wang X, Hu R, Yang W, Liao A, Zhao C, Zhang J, Liu Z (2014c) Methylation of SFRP5 is related to multidrug resistance in leukemia cells. Cancer Gene Ther 21:83–89

    Article  PubMed  CAS  Google Scholar 

  • Wang Y, Yi S, Sun L, Huang Y, Lenaghan SC, Zhang M (2014d) Doxorubicin-loaded cyclic peptide nanotube bundles overcome chemoresistance in breast cancer cells. J Biomed Nanotechnol 10:445–454

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Zhang D, Wu K, Zhao Q, Nie Y, Fan D (2014e) Long non-coding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines. Mol Cell Biol 34:3182–3193

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wang C, Zhao M, Liu YR, Luan X, Guan YY, Lu Q, Yu DH, Bai F, Chen HZ, Fang C (2014f) Suppression of colorectal cancer subcutaneous xenograft and experimental lung metastasis using nanoparticle-mediated drug delivery to tumor neovasculature. Biomaterials 35:1215–1226

    Article  CAS  PubMed  Google Scholar 

  • Wang J, Ma W, Tu P (2015) Synergistically improved anti-tumor efficacy by co-delivery doxorubicin and curcumin polymeric micelles. Macromol Biosci 15:1252–1261

    Article  CAS  PubMed  Google Scholar 

  • Wei Z, Yuan S, Hao J, Fang X (2013) Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity. Eur J Pharm Biopharm 83:266–274

    Article  CAS  PubMed  Google Scholar 

  • Wu WR, Zhang R, Shi XD, Zhu MS, Xu LB, Zeng H, Liu C (2014) Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro. Oncol Rep 31:2515–2524

    CAS  PubMed  Google Scholar 

  • Xing A, Shi D, Liu W, Chen X, Sun Y, Wang X, Zhang J, Gao P (2013) Restoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozyme. Exp Mol Pathol 94:481–485

    Article  CAS  PubMed  Google Scholar 

  • Xiong XB, Lavasanifar A (2011) Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. ACS Nano 5:5202–5213

    Article  CAS  PubMed  Google Scholar 

  • Xu Y, Xia F, Ma L, Bian X, Bie P, Qian C (2011) MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Cancer Lett 310:160–169

    CAS  PubMed  Google Scholar 

  • Xu F, Yang T, Fang D, Xu Q, Chen Y (2014) An investigation of heat shock protein 27 and P-glycoprotein mediated multi-drug resistance in breast cancer using liquid chromatography-tandem mass spectrometry-based targeted proteomics. J Proteomics 108C:188–197

    Article  CAS  Google Scholar 

  • Yamagishi N, Nakao R, Kondo R, Nishitsuji M, Saito Y, Kuga T, Hatayama T, Nakayama Y (2014) Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein. Biochem Biophys Res Commun 448:430–436

    Article  CAS  PubMed  Google Scholar 

  • Yan LH, Wang XT, Yang J, Kong FB, Lian C, Wei WY, Luo W, Xie YB, Xiao Q (2014) Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo. J Cell Biochem 115:34–41

    Article  CAS  PubMed  Google Scholar 

  • Ye Q, Ding SF, Wang ZA, Feng J, Tan WB (2014) Influence of ribosomal protein L39-L in the drug resistance mechanisms of lacrimal gland adenoid cystic carcinoma cells. Asian Pac J Cancer Prev 15:4995–5000

    Article  PubMed  Google Scholar 

  • Yin Y, Li W, Deng M, Zhang P, Shen Q, Wang G, Tao K (2014) Extracellular high mobility group box chromosomal protein 1 promotes drug resistance by increasing the expression of P–glycoprotein expression in gastric adenocarcinoma cells. Mol Med Rep 9:1439–1443

    CAS  PubMed  Google Scholar 

  • Yu P, Yu H, Guo C, Cui Z, Chen X, Yin Q, Zhang P, Yang X, Cui H, Li Y (2015) Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles. Acta Biomater 14:115–124

    Article  CAS  PubMed  Google Scholar 

  • Yun U, Lee J, Koo KH, Ye S, Kim S, Lee C, Kim Y (2013) Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition. Biochem Pharmacol 85:1441–1453

    Article  CAS  PubMed  Google Scholar 

  • Zenga X, Morgensternb R, Nyström AM (2014) Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-Mediated drug resistance. Biomaterials 35:1227–1239

    Article  CAS  Google Scholar 

  • Zhang W, Shi Y, Chen Y, Ye J, Sha X, Fang X (2011) Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials 32:2894–2906

    Article  CAS  PubMed  Google Scholar 

  • Zhang Y, Zhang H, Wang X, Wang J, Zhang X, Zhang Q (2012) The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Biomaterials 33:679–691

    Article  CAS  PubMed  Google Scholar 

  • Zhang ZD, Li Y, Fan LQ, Zhao Q, Tan BB, Zhao XF (2014a) Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway. Neoplasma 61:627–637

    Article  CAS  PubMed  Google Scholar 

  • Zhang H, Sun L, Xiao X, Wei Y, Zhang H, Liu L (2014b) Krüppel-like factor 8 contributes to hypoxia-induced multidrug resistance in gastric cancer cells. Cancer Sci 105:1109–1115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang X, Yang Y, Liang X, Zeng X, Liu Z, Tao W, Xiao X, Chen H, Huang L, Mei L (2014c) Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer. Theranostics 4:1085–1095

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zhang H, Zhang YK, Wang YJ, Kathawala RJ, Patel A, Zhu H, Sodani K, Talele TT, Ambudkar SV, Chen ZS, Fu LW (2014d) WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells. Cancer Sci 105:1071–1078

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang F, Zhang H, Wang Z, Yu M, Tian R, Ji W, Yang Y, Niu R (2014e) P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells. Biochem Pharmacol 87:292–302

    Article  CAS  PubMed  Google Scholar 

  • Zhao X, Chen Q, Li Y, Tang H, Liu W, Yang X (2015) Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Eur J Pharm Biopharm 93:27–36

    Article  CAS  PubMed  Google Scholar 

  • Zheng C, Xu J, Yao X, Xu J, Qiu L (2011) Polyphosphazene nanoparticles for cytoplasmic release of doxorubicin with improved cytotoxicity against Dox-resistant tumor cells. J Colloid Interface Sci 355:374–382

    Article  CAS  PubMed  Google Scholar 

  • Zhou JJ, Deng XG, He XY, Zhou Y, Yu M, Gao WC, Zeng B, Zhou QB, Li ZH, Chen RF (2014) Knockdown of NANOG enhances chemosensitivity of liver cancer cells to doxorubicin by reducing MDR1 expression. Int J Oncol 44:2034–2040

    CAS  PubMed  Google Scholar 

  • Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu C, Yang J (2008) Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 76:582–588

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhu CY, Lv YP, Yan DF, Gao FL (2013) Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells. Asian Pac J Cancer Prev 14:6757–6760

    Article  PubMed  Google Scholar 

  • Zhu H, Chen X, Chen B, Zhou M, Sun D, Zhao Y (2014a) Activating transcription factor 4 mediates a multidrug resistance phenotype of esophageal squamous cell carcinoma cells through transactivation of STAT3 expression. Cancer Lett S0304–3835:00423–00426

    Google Scholar 

  • Zhu X, Li Y, Xie C, Yin X, Liu Y, Cao Y, Fang Y, Lin X, Xu Y, Xu W, Shen H, Wen J (2014b) miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6. Int J Cancer 135:1286–1296

    Article  CAS  PubMed  Google Scholar 

  • Zong C, Wang J, Shi TM (2014) MicroRNA 130b enhances drug resistance in human ovarian cancer cells. Tumour Biol 35:12151–12156

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India

    P. S. Thakur, A. M. Khan, S. Talegaonkar, F. J. Ahmad & Z. Iqbal

Authors
  1. P. S. Thakur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. M. Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Talegaonkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. J. Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Z. Iqbal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Z. Iqbal.

Ethics declarations

Conflict of interest

There is no financial or other competing interest in the work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thakur, P.S., Khan, A.M., Talegaonkar, S. et al. Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer. J Cancer Res Clin Oncol 142, 2073–2106 (2016). https://doi.org/10.1007/s00432-016-2167-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-016-2167-7

Keywords

Search

Navigation